综合的多omics分析揭示了一种精确治疗策略,该策略针对肝细胞癌中的复制应激,使用WEE1抑制来抑制WEE1
Xing Jia1, Xingxin Zhu2, Shinuo Chen2
1Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China; Thyroid Surgery Department, Zhejiang Cancer Hospital, Hangzhou 310022 Zhejiang, China; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou 310003, China; Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences (2019RU019), Hangzhou 310003, China; Key Laboratory of Organ Transplantation, Research Center for Diagnosis and Treatment of Hepatobiliary Diseases, Zhejiang Province, Hangzhou 310003, China.
这项研究确定WEE1是肝细胞癌 (HCC) 的合成致命标,通过将氧沙与阿达沃蒂布结合起来. 这种个性化的方法针对HCC的复制应激 (RS),改善患者的预后.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 肝细胞癌 (HCC) 是一种异质的恶性瘤,预后不佳.
- 针对特定的瘤脆弱性对于有效的HCC治疗至关重要.
研究的目的:
- 通过使用多omics分析,为HCC患者提供针对个性化治疗策略的新见解.
- 确定针对HCC的复制应激 (RS) 的新型治疗策略.
主要方法:
- 178个和94个初级HCC样本的蛋白质和转录组测序.
- 基因组CRISPR-Cas9查以确定复制压力的目标.
- 在体外和体内验证氧沙与阿达沃谢蒂布之间的协同作用.
主要成果:
- 超增殖性HCC亚型显示出最差的预后和最高的RS水平.
- 奥克萨利普拉丁诱导了最高的RS水平,但面临着耐药性挑战.
- 确定WEE1是氧沙的合成致命标; 通过抑制DNA修复并导致致命的DNA损伤,阿达沃谢蒂布证明了协同作用.
结论:
- 通过WEE1抑制向复制应激 (RS),特别是通过阿达沃谢蒂布和氧沙,显示出对HCC治疗的希望.
- 基于蛋白质组和转录组RS水平,可以开发针对HCC的个性化治疗策略.
- 与阿达沃谢蒂布和氧沙利普拉丁的联合治疗可能有利于高RS水平的HCC患者.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
DNA Damage can Stall the Cell Cycle
